The Standard care versus Celecoxib Outcome Trial (SCOT trial): A Large Streamlined Safety Study.

Trial Profile

The Standard care versus Celecoxib Outcome Trial (SCOT trial): A Large Streamlined Safety Study.

Completed
Phase of Trial: Phase IV

Latest Information Update: 26 Dec 2016

At a glance

  • Drugs Celecoxib (Primary) ; Diclofenac; Ibuprofen; Meloxicam; Naproxen
  • Indications Osteoarthritis; Rheumatoid arthritis
  • Focus Adverse reactions
  • Acronyms SCOT; SCOTLSSS
  • Most Recent Events

    • 07 Jan 2016 Status changed from active, no longer recruiting to completed, as reported by ClinicalTrials.gov.
    • 06 Jul 2015 Planned End Date changed from 1 Feb 2015 to 1 Jul 2015 as per ClinicalTrials.gov record.
    • 06 Jul 2015 Planned primary completion date changed from 1 Feb 2015 to 1 Jul 2015 as per ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top